AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 1-25/131
2ND NEOPLASMS FOLLOWING HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR MALIGNANT-LYMPHOMAS - A REPORT OF 6 CASES IN A COHORT OF 171 PATIENTS FROM A SINGLE INSTITUTION
Authors: ODDOU S VEY N VIENS P BARDOU VJ FAUCHER C STOPPA AM CHABANNON C CAMERLO J BOUABDALLAH R GASTAUT JA MARANINCHI D BLAISE D
Citation: S. Oddou et al., 2ND NEOPLASMS FOLLOWING HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR MALIGNANT-LYMPHOMAS - A REPORT OF 6 CASES IN A COHORT OF 171 PATIENTS FROM A SINGLE INSTITUTION, Leukemia & lymphoma, 31(1-2), 1998, pp. 187-194
ROLE OF INDUCTION CHEMOTHERAPY AND BONE-MARROW TRANSPLANTATION IN ADULT LYMPHOBLASTIC LYMPHOMA - A REPORT ON 62 PATIENTS FROM A SINGLE-CENTER
Authors: BOUABDALLAH R XERRI L BARDOU VJ STOPPA AM BLAISE D SAINTY D MARANINCHI D GASTAUT JA
Citation: R. Bouabdallah et al., ROLE OF INDUCTION CHEMOTHERAPY AND BONE-MARROW TRANSPLANTATION IN ADULT LYMPHOBLASTIC LYMPHOMA - A REPORT ON 62 PATIENTS FROM A SINGLE-CENTER, Annals of oncology, 9(6), 1998, pp. 619-625
OUTCOME OF PATIENTS AT HIGH-RISK OF DEVELOPING GVHD, AFTER ALLOGENEICTRANSPLANTATION OF SELECTED CD34-CELLS( BLOOD)
Authors: CHABANNON C AURRAN T VIRET F FAUCHER C STOPPA AM LADAIQUE P VEY N BOUABDALLAH R NOVAKOVITCH G GASTAUT JA MARANINCHI D BLAISE D
Citation: C. Chabannon et al., OUTCOME OF PATIENTS AT HIGH-RISK OF DEVELOPING GVHD, AFTER ALLOGENEICTRANSPLANTATION OF SELECTED CD34-CELLS( BLOOD), Experimental hematology, 26(8), 1998, pp. 364-364
HIGH-DOSE CHEMOTHERAPY AND HEMATOPOIETIC STEM-CELL TRANSPLANTATION FOR INFLAMMATORY BREAST-CANCER - PATHOLOGICAL RESPONSE AND OUTCOME
Authors: VIENS P PENAULTLLORCA F JACQUEMIER J GRAVIS G COWEN D BERTUCCI F HOUVENAEGHEL G BLAISE D MARANINCHI D
Citation: P. Viens et al., HIGH-DOSE CHEMOTHERAPY AND HEMATOPOIETIC STEM-CELL TRANSPLANTATION FOR INFLAMMATORY BREAST-CANCER - PATHOLOGICAL RESPONSE AND OUTCOME, Bone marrow transplantation, 21(3), 1998, pp. 249-254
CLINICAL ECONOMIC AND QUALITY-OF-LIFE ASSESSMENT OF LENOGRASTIM PRIMING AND PERIPHERAL-BLOOD PROGENITOR CELLS (PBSC) HARVESTING FOR 31 HEALTHY DONORS
Authors: FAUCHER C FORTANIER C LECORROLLER AG CHABANNON C MAQUARTMOULIN G NOVAKOVITCH G CHABBERT I SCHULLER MP MARANINCHI D MOATTI JP BLAISE D
Citation: C. Faucher et al., CLINICAL ECONOMIC AND QUALITY-OF-LIFE ASSESSMENT OF LENOGRASTIM PRIMING AND PERIPHERAL-BLOOD PROGENITOR CELLS (PBSC) HARVESTING FOR 31 HEALTHY DONORS, Bone marrow transplantation, 21, 1998, pp. 1-1
PSYCHOSOCIAL-ASPECTS OF PERIPHERAL-BLOOD STEM-CELLS DONATION FOR ALLOGENEIC TRANSPLANTATION - THE EXPERIENCE OF FAMILIAL DONORS
Authors: MUNZENBERGER N FAUCHER C NOVAKOVITCH G MARANINCHI D BLAISE D MOATTI JP
Citation: N. Munzenberger et al., PSYCHOSOCIAL-ASPECTS OF PERIPHERAL-BLOOD STEM-CELLS DONATION FOR ALLOGENEIC TRANSPLANTATION - THE EXPERIENCE OF FAMILIAL DONORS, Bone marrow transplantation, 21, 1998, pp. 9-9
CLINICAL AND ECONOMIC COMPARISON OF LENOGRASTIM-PRIMED BLOOD-CELLS (BC) AND BONE-MARROW (BM) ALLOGENEIC TRANSPLANTATION
Authors: FAUCHER C FORTANIER C VIENS P LECORROLLER AG CHABANNON C CAMERLO J NOVAKOVITCH G GASTAUT JA MARANINCHI D MOATTI JP BLAISE D
Citation: C. Faucher et al., CLINICAL AND ECONOMIC COMPARISON OF LENOGRASTIM-PRIMED BLOOD-CELLS (BC) AND BONE-MARROW (BM) ALLOGENEIC TRANSPLANTATION, Bone marrow transplantation, 21, 1998, pp. 92-98
EFFECTIVE T-CELL DEPLETION OF ALLOGENEIC BLOOD AND MARROW GRAFTS, USING A CD34+ CELL SELECTION DEVICE
Authors: VIRET F CHABANNON C VEY N STOPPA AM FAUCHER C NOVAKOVITCH G OZIELTAIEB S GASTAUT JA MARANINCHI D BLAISE D
Citation: F. Viret et al., EFFECTIVE T-CELL DEPLETION OF ALLOGENEIC BLOOD AND MARROW GRAFTS, USING A CD34+ CELL SELECTION DEVICE, Bone marrow transplantation, 21, 1998, pp. 102-102
IMMUNE RECOVERY AFTER ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL (PBSC) TRANSPLANTATION - A COMPARATIVE-STUDY OF 78 PATIENTS
Authors: CHARBONNIER A SAINTY D ARNOULET C FAUCHER C VIRET F VEY N STOPPA AM CHABANNON C MARANINCHI D BLAISE D
Citation: A. Charbonnier et al., IMMUNE RECOVERY AFTER ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL (PBSC) TRANSPLANTATION - A COMPARATIVE-STUDY OF 78 PATIENTS, Bone marrow transplantation, 21, 1998, pp. 103-103
IMPACT OF ALLOGENEIC PBSC TRANSPLANTATION OVER THE AGE OF 45
Authors: BLAISE D JOURDAN E FEGUEUX N MICHALLET M REIFFERS J JOUET JP FAUCHER C FORTANIER C SCHULLER MP BADRI N CHABANNON C MARANINCHI D
Citation: D. Blaise et al., IMPACT OF ALLOGENEIC PBSC TRANSPLANTATION OVER THE AGE OF 45, Bone marrow transplantation, 21, 1998, pp. 103-103
IMPACT OF ALLOGENEIC PBSC TRANSPLANTATION IN A POPULATION OF STANDARDRISK PATIENT
Authors: BLAISE D JOURDAN E FEGUEUX N MICHALLET M REIFFERS J JOUET JP MICHEL G FAUCHER C FORTANIER C SCHULLER MP BADRI N CHABANNON C MARANINCHI D
Citation: D. Blaise et al., IMPACT OF ALLOGENEIC PBSC TRANSPLANTATION IN A POPULATION OF STANDARDRISK PATIENT, Bone marrow transplantation, 21, 1998, pp. 103-103
CLINICAL ECONOMIC AND QUALITY-OF-LIFE ASSESSMENT OF LENOGRASTIM PRIMING AND PERIPHERAL-BLOOD PROGENITOR CELLS (PBSC) HARVESTING FOR 31 HEALTHY DONORS
Authors: FAUCHER C FORTANIER C LECORROLLER AG CHABANNON C MAQUARTMOULIN G NOVAKOVITCH G CHABBERT I SCHULLER MP MARANINCHI D MOATTI JP BLAISE D
Citation: C. Faucher et al., CLINICAL ECONOMIC AND QUALITY-OF-LIFE ASSESSMENT OF LENOGRASTIM PRIMING AND PERIPHERAL-BLOOD PROGENITOR CELLS (PBSC) HARVESTING FOR 31 HEALTHY DONORS, Bone marrow transplantation, 21, 1998, pp. 146-146
IMPACT OF ALLOGENEIC PBSC TRANSPLANTATION IN A POPULATION OF STANDARDRISK PATIENT
Authors: BLAISE D JOURDAN E FEGUEUX N MICHALLET M REIFFERS J JOUET JP MICHEL G FAUCHER C FORTANIER C SCHULLER MP BADRI N CHABANNON C MARANINCHI D
Citation: D. Blaise et al., IMPACT OF ALLOGENEIC PBSC TRANSPLANTATION IN A POPULATION OF STANDARDRISK PATIENT, Bone marrow transplantation, 21, 1998, pp. 147-147
EARLY AND PROLONGED (D1-86) ADMINISTRATION OF LOW-DOSE INTERLEUKIN-2 AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR HEMATOLOGIC MALIGNANCIES
Authors: STOPPE AM VEY N VIRET F FAUCHET C CHABANNON C CAMERLO J CAPPIELLO M BLAISE D MARANINCHI D
Citation: Am. Stoppe et al., EARLY AND PROLONGED (D1-86) ADMINISTRATION OF LOW-DOSE INTERLEUKIN-2 AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR HEMATOLOGIC MALIGNANCIES, Bone marrow transplantation, 21, 1998, pp. 363-363
RANDOMIZED STUDY OF INTERLEUKIN-2 (RIL2) AFTER AUTOLOGOUS BONE-MARROWTRANSPLANTATION (BMT) IN 78 PATIENTS WITH ACUTE MYELOID-LEUKEMIA (AL)IN FIRST COMPLETE REMISSION (CR-1) - RESULTS OF A MULTICENTRIC TRIAL WITH A 5-YEAR FOLLOW-UP
Authors: BLAISE D REIFFERS J ATTAL M STOPPA AM MARIT G HUGUET F MOLINA L PICO JL GABUS R BRANDELY M HERCEND T MARANINCHI D
Citation: D. Blaise et al., RANDOMIZED STUDY OF INTERLEUKIN-2 (RIL2) AFTER AUTOLOGOUS BONE-MARROWTRANSPLANTATION (BMT) IN 78 PATIENTS WITH ACUTE MYELOID-LEUKEMIA (AL)IN FIRST COMPLETE REMISSION (CR-1) - RESULTS OF A MULTICENTRIC TRIAL WITH A 5-YEAR FOLLOW-UP, Bone marrow transplantation, 21, 1998, pp. 368-368
ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR REFRACTORY AND RECURRENT FOLLICULAR LYMPHOMA - A CASE-MATCHED ANALYSIS WITH AUTOLOGOUS TRANSPLANTATION FROM THE FRENCH BONE-MARROW TRANSPLANT GROUP REGISTRY DATA
Authors: ATTAL M SOCIE G MOLINA L JOUET JP PICO J KUENTZ M BLAISE D MILPIED N IFRAH N PAYEN C TANGUY ML
Citation: M. Attal et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR REFRACTORY AND RECURRENT FOLLICULAR LYMPHOMA - A CASE-MATCHED ANALYSIS WITH AUTOLOGOUS TRANSPLANTATION FROM THE FRENCH BONE-MARROW TRANSPLANT GROUP REGISTRY DATA, Bone marrow transplantation, 21, 1998, pp. 601-601
PREDICTIVE FACTORS AFFECTING COLLECTION OF PERIPHERAL-BLOOD STEM-CELLS (PBSC) IN PATIENTS WITH VARIOUS MALIGNANCIES
Authors: TUPPIN P LADAIQUE P CHABANON C VIENS P STOPA AM BLAISE D NOVAKOVITCH G
Citation: P. Tuppin et al., PREDICTIVE FACTORS AFFECTING COLLECTION OF PERIPHERAL-BLOOD STEM-CELLS (PBSC) IN PATIENTS WITH VARIOUS MALIGNANCIES, Bone marrow transplantation, 21, 1998, pp. 662-662
CONSTITUTIONAL BALANCED PERICENTRIC INVERSIONS OF CHROMOSOME-X, CHROMOSOME-2, AND CHROMOSOME-5 IN MYELOID MALIGNANCIES
Authors: MOZZICONACCI MJ SOBOL H PHILIP N STOPPA AM BRUNEL V GRANEL B BLAISE D SAINTY D BIRNBAUM D LAFAGEPOCHITALOFF M
Citation: Mj. Mozziconacci et al., CONSTITUTIONAL BALANCED PERICENTRIC INVERSIONS OF CHROMOSOME-X, CHROMOSOME-2, AND CHROMOSOME-5 IN MYELOID MALIGNANCIES, Cancer genetics and cytogenetics, 107(1), 1998, pp. 28-31
CD34-SAMPLES OR APHERESIS USING DIAGNOSTIC KITS OR AN INSTITUTIONAL PROTOCOL( CELL COUNTS IN BLOOD)
Authors: OLIVERO S LADAIQUE P ALARIO T HACCOUN M NOVAKOVITCH G VIENS P BLAISE D CHABANNON C
Citation: S. Olivero et al., CD34-SAMPLES OR APHERESIS USING DIAGNOSTIC KITS OR AN INSTITUTIONAL PROTOCOL( CELL COUNTS IN BLOOD), British Journal of Haematology, 102(1), 1998, pp. 75-75
RANDOMIZED STUDY OF INTERLEUKIN-2 (RIL2) AFTER AUTOLOGOUS BONE-MARROWTRANSPLANTATION (BMT) IN 130 PATIENTS WITH ACUTE-LEUKEMIA (AL) IN FIRST COMPLETE REMISSION (CR-1) - RESULTS OF A MULTICENTRIC TRIAL WITH A 5-YEAR FOLLOW-UP
Authors: BLAISE D ATTAI M REIFFERS J STOPPA AM HUGUET F MARIT G MOLINA L BELLANGER C PICO JL GABUS R BRANDELY M HERCEND T MARANINCHI D
Citation: D. Blaise et al., RANDOMIZED STUDY OF INTERLEUKIN-2 (RIL2) AFTER AUTOLOGOUS BONE-MARROWTRANSPLANTATION (BMT) IN 130 PATIENTS WITH ACUTE-LEUKEMIA (AL) IN FIRST COMPLETE REMISSION (CR-1) - RESULTS OF A MULTICENTRIC TRIAL WITH A 5-YEAR FOLLOW-UP, British Journal of Haematology, 102(1), 1998, pp. 89-89
INTENSIVE THERAPY IN 100 PATIENTS WITH PH1 AND OR BCR-ABL POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - FIRST INTERIM ANALYSIS OF THE FRENCH-BELGIAN-AUSTRALIAN LALA-94 TRIAL/
Authors: DOMBRET H THOMAS X BLAISE D HUGUET F BOIRON JM BUZYN A STAMATOULAS A DELANNOY A BRADSTOCK K BOUCHEIX C CHARRIN C GABERT J LEBBE G LHERITIER V FIERE D
Citation: H. Dombret et al., INTENSIVE THERAPY IN 100 PATIENTS WITH PH1 AND OR BCR-ABL POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - FIRST INTERIM ANALYSIS OF THE FRENCH-BELGIAN-AUSTRALIAN LALA-94 TRIAL/, British Journal of Haematology, 102(1), 1998, pp. 270-270
OUTCOME OF PATIENTS AT HIGH-RISK OF DEVELOPING GVHD, AFTER ALLOGENEICTRANSPLANTATION OF SELECTED CD34-CELLS( BLOOD)
Authors: CHABANNON C AURRANSCHLEINITZ T VIRET F FAUCHER C STOPPA AM LADAIQUE R VEY N BOUABDALLAH R NOVAKOVITCH G GASTAUT JA MARANINCHI D BLAISE D
Citation: C. Chabannon et al., OUTCOME OF PATIENTS AT HIGH-RISK OF DEVELOPING GVHD, AFTER ALLOGENEICTRANSPLANTATION OF SELECTED CD34-CELLS( BLOOD), British Journal of Haematology, 102(1), 1998, pp. 319-319
HIGH-DOSE CHEMOTHERAPY FOLLOWED BY REINFUSION OF SELECTED CD34(-BLOODCELLS IN PATIENTS WITH POOR-PROGNOSIS BREAST-CANCER - A RANDOMIZED MULTICENTER STUDY() PERIPHERAL)
Authors: CHABANNON C CORNETTA K LOTZ JP ROSENFELD C SHLOMCHIK M YANOVITCH S MAROLLEAU JP SLEDGE G NOVAKOVITCH G SROUR EF BURTNESS B CAMERLO J GRAVIS G LEEFISCHER J FAUCHER C CHABBERT I KRAUSE D MARANINCHI D MILLS B KUNKEL L OLDHAM F BLAISE D VIENS P
Citation: C. Chabannon et al., HIGH-DOSE CHEMOTHERAPY FOLLOWED BY REINFUSION OF SELECTED CD34(-BLOODCELLS IN PATIENTS WITH POOR-PROGNOSIS BREAST-CANCER - A RANDOMIZED MULTICENTER STUDY() PERIPHERAL), British Journal of Cancer, 78(7), 1998, pp. 913-921
TREATMENT-RELATED DEATHS AND 2ND CANCER RISK AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR HODGKINS-DISEASE
Authors: ANDRE M HENRYAMAR M BLAISE D COLOMBAT P FLEURY J MILPIED N CAHN JY PICO JL BASTION Y KUENTZ M NEDELLEC G ATTAL M FERME C GISSELBRECHT C
Citation: M. Andre et al., TREATMENT-RELATED DEATHS AND 2ND CANCER RISK AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR HODGKINS-DISEASE, Blood, 92(6), 1998, pp. 1933-1940
IMMUNE RECONSTITUTION AFTER BLOOD-CELL TRANSPLANTATION
Authors: CHARBONNIER A SAINTY D FAUCHER C ARNOULET C CHABANNON C BLAISE D
Citation: A. Charbonnier et al., IMMUNE RECONSTITUTION AFTER BLOOD-CELL TRANSPLANTATION, HEM CELL TH, 39(5), 1997, pp. 261-264
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>